Healthcare & Life Sciences

Healthcare regulation increasingly determines commercial outcomes.

We advise pharmaceutical, biotechnology, medical device, and digital health companies navigating:

• Drug pricing and reimbursement reform

• Market access and payer dynamics

• Biosimilars and competitive policy frameworks

• Supply chain resilience and trade exposure

• Transatlantic regulatory divergence

• Federal, state, and EU health policy developments

Across jurisdictions, healthcare companies must align commercial strategy with evolving reimbursement systems, pricing scrutiny, and enforcement posture. We help leadership teams anticipate policy shifts before they affect growth.

Technology & Innovation

Healthcare regulation increasingly determines commercial outcomes.

We advise clients navigating:

• Emerging technology oversight

• Digital governance and regulatory convergence

• Data protection and cross-border compliance dynamics

• National security screening and foreign investment review

• Innovation policy and enforcement trends

As EU, UK, and U.S. regulators expand oversight of artificial intelligence, digital platforms, cybersecurity, and data flows, regulatory alignment has become a core executive function. We help companies integrate policy strategy into product development and market expansion planning.